ErinFrancesCobainMD

Physician

Dr. Cobain is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1500 E Medical Center Dr FL B1
Ann Arbor, MI 48109
Phone+1 734-936-4000

University of MichiganFellowship, Hematology and Medical Oncology, 2013 - 2016
University of Pennsylvania Health SystemResidency, Internal Medicine, 2009 - 2012
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2009

PubMed

Psychological Considerations Associated with Lobular Breast Cancer.
Jasmine C Walker, Shivali Patel, Erin F Cobain, Celina G Kleer, Colleen H Neal
Current Psychiatry Reports. 2024-12-17
Hormone Receptor Positive HER2-negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple Negative Breast Cancers.
Alejandro Rios-Hoyo, Kaitlyn Xiong, Jiawei Dai, Christina Yau, Michal Marczyk
Clinical Cancer Research. 2024-11-19
2 citations
Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer.
Alejandro Ríos-Hoyo, Erin Cobain, Laura A Huppert, Peter D Beitsch, Thomas A Buchholz
Journal of Clinical Oncology. 2024-08-01

Journal Articles

Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors
Erin F Cobain, Francis Worden, Scott M Schuetze, Mark M Zalupski, Vaibhav Sahai, Ajjai Alva, Anne F Schott, Moshe Talpaz, JAMA Oncology

What 3 Big Trials Mean for Breast Cancer PracticeOctober 28th, 2024
New Finding “Changes the Conversation” in Metastatic Breast Cancer CareOctober 22nd, 2024
Without New FDA Approval, How Should Adjuvant Ribociclib Be Used in Breast Cancer?August 20th, 2024
Join now to see all